Peripheral vascular disease (PVD) occurs when a buildup of plaque and other substances blocks or narrows arteries, limiting or halting blood flow. The condition is also called peripheral artery disease (PAD).
PVD: what you should know
Many people with PVD don't have symptoms, but there are signs to watch for:
- Claudication — a burning or tired feeling in the leg while walking, climbing stairs or exercising that generally goes away with rest
- Extreme leg pain (in severe cases)
- Sores in the legs and feet
- Risk factors for PVD include the following:
There are ways to help prevent PVD:
- Do not smoke or quit smoking
- Eat a healthy diet
- Maintain a healthy weight
Care for peripheral vascular disease at Rush
Since people with PVD may not experience symptoms, patients at high risk for the disease should get regular checkups. Early detection can help restore your mobility, decrease your risk of heart attack and stroke, and possibly save your life.
If you are diagnosed with PVD, specialists at Rush collaborate across disciplines to create a personalized treatment plan for you. That plan may include the following:
- Lifestyle changes, including diet and exercise
- Diabetes management
- Medications to lower blood pressure or cholesterol levels (or both)
- Angioplasty, a minimally invasive procedure to increase blood flow to the legs
- Bypass surgery to restore blood flow
Why choose Rush for peripheral vascular disease care
- U.S. News & World Report consistently ranks Rush’s heart program among the best in the country.
- Rush is the first Chicago hospital to use a lumivascular technique combining imaging and therapy on a single device to unblock clogged arteries. This outpatient procedure uses a dime-sized incision and can provide an alternative to bypass surgery.
- The interventional platform in Rush's new hospital has state-of-the-art procedure rooms that allow for a collaborative treatment approach for a wide range of conditions, including peripheral vascular disease.
- Specialists at Rush are leaders in research on peripheral vascular disease, so they are able to offer patients many new treatments before they are widely available.